Article

Pre-clinical efficacy of a candidate Outer Membrane Vesicle gonococcal vaccine in comparison with 4CMenB.

2026-01-30

Abstract excerpt

<title>Abstract</title> <p> <italic>Neisseria gonorrhoeae</italic> causes 82 million global cases of gonorrhoea annually. Multidrug-resistant gonococci threaten to make gonorrhoea untreatable. Meningococcal vaccines MeNZB and 4CMenB (Bexsero), containing <italic>Neisseria meningitidis</italic> group B detergent-extracted outer membrane vesicles (dOMV), cross-protect against gonorrhoea with 31–59% effectivenes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c9ae3231-3141-5db1-95d4-fc9f1975452e
DOI: 10.21203/rs.3.rs-8595864/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pre-clinical efficacy of a candidate Outer Membrane Vesicle gonococcal vaccine in comparison with 4CMenB.DOI 10.21203/rs.3.rs-8595864/v1Read

The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeaeSemantic proximity Read

Preclinical Evaluation of Novel Conserved <em>Neisseria gonorrhoeae</em> Vaccine Candidates Identified Through Infection-Informed Antigen DiscoverySemantic proximity Read

Efficacy of the Serogroup B <i>Neisseria meningitidis</i> Vaccine (4CMenB) in Preventing Experimental <i>Neisseria gonorrhoeae</i> Urethral Infection: A Double-Blind Randomized Controlled Human Challenge Study ProtocolSemantic proximity Read

An mRNA–Lipid Nanoparticle Platform Encoding the Conserved Outer Membrane Protein BamA Elicits Broadly Cross-Reactive Systemic and Mucosal Antibodies Against Antimicrobial-Resistant <i>Neisseria gonorrhoeae</i>Semantic proximity Read

Novel approaches to Neisseria meningitidis vaccine designSemantic proximity Read

Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B VaccineSemantic proximity Read

Bexsero® chronicleSemantic proximity Read

<i>Neisseria meningitidis</i>B vaccines: recent advances and possible immunization policiesSemantic proximity Read

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeaeSemantic proximity Read

Meningococcal vaccine Bexsero elicits a robust cellular immune response that targets but is not consistently protective against <i>Neisseria gonorrhoeae</i> during murine vaginal infectionSemantic proximity Read

Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process.Semantic proximity Read

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control studySemantic proximity Read